UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis and Management of Pediatric Psoriasis: An Overview for Pediatricians

Journal of drugs in dermatology, 2023-08, Vol.22 (8), p.742-753

2023

Volltextzugriff (PDF)

Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo

Journal of drugs in dermatology, 2021-02, Vol.20 (2), p.134-142

2021

Volltextzugriff (PDF)

Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials

American journal of clinical dermatology, 2023-09, Vol.24 (5), p.821-835

2023

Volltextzugriff (PDF)

Treatment of Impetigo in the Pediatric Population: Consensus and Future Directions

Journal of drugs in dermatology, 2020-03, Vol.19 (3), p.281-290

2020

Volltextzugriff (PDF)

Infantile histiocytoid Sweet syndrome without an underlying systemic association

JAAD Case Reports, 2021-11, Vol.17, p.96-99

2021

Volltextzugriff (PDF)

Topical tacrolimus in the treatment of inverse psoriasis in children

Journal of the American Academy of Dermatology, 2005-10, Vol.53 (4), p.713-716

2005

Volltextzugriff (PDF)

40148 Phase 3 Pooled Analysis Of Safety And Efficacy Of Trifarotene 0.005% Cream Within The Adolescent Population

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB207-AB207

2023

Volltextzugriff (PDF)

Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials

JAMA dermatology (Chicago, Ill.), 2020-12, Vol.156 (12), p.1315

2020

Volltextzugriff (PDF)

13772 Safety and efficacy of VP-102 in molluscum contagiosum (MC) by lesion count quartile: Pooled results of two phase 3 multicenter, randomized, vehicle-controlled trials for the topical treatment of MC

Journal of the American Academy of Dermatology, 2020-12, Vol.83 (6), p.AB13-AB13

2020

Volltextzugriff (PDF)

726 - Interim results from ADmirable, a phase 3b open-label study assessing lebrikizumab in patients with skin of color and moderate-to-severe atopic dermatitis

British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)

2024

Volltextzugriff (PDF)

Treatment of Nevus comedonicus with topical tazarotene and calcipotriene

Journal of drugs in dermatology, 2004-11, Vol.3 (6), p.674

2004

Volltextzugriff (PDF)

Spectrum of Phenotypic Manifestations from a Single Point Mutation of the p63 Gene, Including New Cutaneous and Immunologic Findings

Pediatric dermatology, 2005-09, Vol.22 (5), p.415-419

2005

Volltextzugriff (PDF)

Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis

Journal of drugs in dermatology, 2023-08, Vol.22 (8), p.736-741

2023

Volltextzugriff (PDF)

VP-102 Tolerability Evaluated by Concomitant Analgesic Medication Usage in Two Phase 3 Trials for Molluscum Contagiosum

Skin (Milwood, N.Y.), 2024-03, Vol.8 (2), p.s401

2024

Volltextzugriff (PDF)

514 - Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age

British journal of dermatology (1951), 2024-02, Vol.190 (Supplement_2), p.ii17-ii18

2024

Volltextzugriff (PDF)

Racial and Ethnic Variations in Skin Barrier Properties and Cultural Practices in Skin of Color Newborns, Infants, and Children

Journal of drugs in dermatology, 2023-07, Vol.22 (7), p.657-663

2023

Volltextzugriff (PDF)

Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.457-465

2024

Volltextzugriff (PDF)

Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum

American journal of clinical dermatology, 2021-03, Vol.22 (2), p.257-265

2021

Volltextzugriff (PDF)

Anterior encephalocele with subcutaneous right facial nodule

Journal of the American Academy of Dermatology, 2004-08, Vol.51 (2), p.77-79

2004

Volltextzugriff (PDF)

Advances in Topical Management of Adolescent Facial and Truncal Acne: A Phase 3 Pooled Analysis of Safety and Efficacy of Trifarotene 0.005% Cream

Journal of drugs in dermatology, 2022-06, Vol.21 (6), p.582-586

2022

Volltextzugriff (PDF)

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial

JAMA dermatology (Chicago, Ill.), 2022-05, Vol.158 (5), p.533

2022

Volltextzugriff (PDF)

Autosensitization due to Pediculosis Capitis (a “Pediculid”) in a 16-Year Old Female: A Case Report

Skin (Milwood, N.Y.), 2020-09, Vol.4 (5), p.478-480

2020

Volltextzugriff (PDF)

Review of Mechanisms of Release of Commonly Prescribed Tetracyclines

Skin (Milwood, N.Y.), 2020-10, Vol.4 (6), p.s110

2020

Volltextzugriff (PDF)

Impact of Topical Vehicles and Cutaneous Delivery Technologies on Patient Adherence and Treatment Outcomes in Acne and Rosacea

The Journal of clinical and aesthetic dermatology, 2023-05, Vol.16 (5), p.26-34

2023

Volltextzugriff (PDF)

Management and Referral Patterns in Pediatric Atopic Dermatitis: A Survey of Pediatric Healthcare Professionals

Skin (Milwood, N.Y.), 2020-09, Vol.4 (5), p.408-416

2020

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Diagnosis and Management of Pediatric Psoriasis: An Overview for Pediatricians

Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo

Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials

Treatment of Impetigo in the Pediatric Population: Consensus and Future Directions

Infantile histiocytoid Sweet syndrome without an underlying systemic association

Topical tacrolimus in the treatment of inverse psoriasis in children

40148 Phase 3 Pooled Analysis Of Safety And Efficacy Of Trifarotene 0.005% Cream Within The Adolescent Population

Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials

13772 Safety and efficacy of VP-102 in molluscum contagiosum (MC) by lesion count quartile: Pooled results of two phase 3 multicenter, randomized, vehicle-controlled trials for the topical treatment of MC

726 - Interim results from ADmirable, a phase 3b open-label study assessing lebrikizumab in patients with skin of color and moderate-to-severe atopic dermatitis

Treatment of Nevus comedonicus with topical tazarotene and calcipotriene

Spectrum of Phenotypic Manifestations from a Single Point Mutation of the p63 Gene, Including New Cutaneous and Immunologic Findings

Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis

VP-102 Tolerability Evaluated by Concomitant Analgesic Medication Usage in Two Phase 3 Trials for Molluscum Contagiosum

514 - Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age

Racial and Ethnic Variations in Skin Barrier Properties and Cultural Practices in Skin of Color Newborns, Infants, and Children

Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials

Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum

Anterior encephalocele with subcutaneous right facial nodule

Advances in Topical Management of Adolescent Facial and Truncal Acne: A Phase 3 Pooled Analysis of Safety and Efficacy of Trifarotene 0.005% Cream

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial

Autosensitization due to Pediculosis Capitis (a “Pediculid”) in a 16-Year Old Female: A Case Report

Review of Mechanisms of Release of Commonly Prescribed Tetracyclines

Impact of Topical Vehicles and Cutaneous Delivery Technologies on Patient Adherence and Treatment Outcomes in Acne and Rosacea

Management and Referral Patterns in Pediatric Atopic Dermatitis: A Survey of Pediatric Healthcare Professionals

Suchergebnisse filtern